HCMT
NVET

Highland Capital Management (Texas)’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Highland Capital Management (Texas)’s Portfolio NVET Stock Details NVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-105,000
Closed -$702K – 371
2017
Q2 		$702K Buy
+105,000
New +$660K 0.03% 191

Highland Capital Management (Texas)'s NVET Position: Q3 2017 in Review

Highland Capital Management (Texas) sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q3 2017, closing a stake of 105,000 shares — an estimated $702K sold.

Highland Capital Management (Texas) first reported a position in NVET in Q2 2017 and held it in 1 quarter. The position peaked at $702K in Q2 2017. 0 funds tracked by Wall St. Rank hold NVET as of Q3 2017.

  • Highland Capital Management (Texas) reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q3 2017 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 105,000 Nexvet Biopharma plc Ordinary Shares shares in Q3 2017, an estimated $702K.
  • Highland Capital Management (Texas) first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2017 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s Nexvet Biopharma plc Ordinary Shares position peaked at $702K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q3 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2017, filed 14 Nov 2017.